Autoimmune nodopathies, an emerging diagnostic category.
Martín-Aguilar L, Lleixà C, Pascual-Goñi E.
Curr Opin Neurol. 2022 Oct 1;35(5):579-585. doi: 10.1097/WCO.0000000000001107. Epub 2022 Aug 19.
Ischemic peripheral neuropathy.
Ugalde V, Rosen BS.
Phys Med Rehabil Clin N Am. 2001 May;12(2):365-80.
Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary.
Collins MP, Dyck PJ, Gronseth GS, Guillevin L, Hadden RD, Heuss D, Léger JM, Notermans NC, Pollard JD, Said G, Sobue G, Vrancken AF, Kissel JT; Peripheral Nerve Society.
J Peripher Nerv Syst. 2010 Sep;15(3):176-84. doi: 10.1111/j.1529-8027.2010.00281.x.
Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T, Kandula T, Cohn RJ, Kiernan MC, Park SB, Farrar MA.
Clin Neurophysiol. 2023 Oct;154:157-168. doi: 10.1016/j.clinph.2023.08.002. Epub 2023 Aug 11.
Radiation-Induced Lumbosacral Plexopathy.
Almeida LR, Faustino D, Esteves LR, Gante C, Soares AW, Oliveira T, Dias JL, Dias L.
Cureus. 2023 Mar 29;15(3):e36842. doi: 10.7759/cureus.36842. eCollection 2023 Mar.
[Disulfiram-induced polyneurophaty].
Vujisić S, Radulović L, Knezević-Apostolski S, Petković S, Vukmirović F, Apostolski S.
Vojnosanit Pregl. 2012 May;69(5):453-7. doi: 10.2298/vsp1205453v.
COVID-19 Neuromuscular Involvement in Post-Acute Rehabilitation.
Bagnato S, Ferraro M, Boccagni C, Battaglia G, D'Agostino T, Prestandrea C, Bellavia MA, Rubino F.
Brain Sci. 2021 Dec 6;11(12):1611. doi: 10.3390/brainsci11121611.
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia.
Raj TA, Smith AM, Moore AS.
Int J Nanomedicine. 2013;8:4361-9. doi: 10.2147/IJN.S54657. Epub 2013 Nov 6.
Critical illness myopathy and neuropathy.
Latronico N, Guarneri B.
Minerva Anestesiol. 2008 Jun;74(6):319-23.
Antibody testing in peripheral nerve disorders.
Steck A, Yuki N, Graus F.
Handb Clin Neurol. 2013;115:189-212. doi: 10.1016/B978-0-444-52902-2.00011-4.
